Pre-Conference Workshops


Workshop: Exercise Medicine Research and Clinical Practice in Cancer

Date: 20th April 2015
Time: 2.00pm - 5.00pm
Venue: Edith Cowan University Health and Wellness Institute,
                Reception, Building 21, Edith Cowan University, Joondalup campus

Appropriately prescribed exercise has been proven to increase quality and quantity of life for people with cancer. In this workshop we will explore the latest scientific findings and present pragmatic implementation of exercise medicine for cancer patients.

A series of short presentations of our clinical trials of exercise for a range of cancer patients including prostate, breast, lung, and pancreas will be followed by a hands-on practical session of the assessments we use for research and clinical management of patients including body composition, balance, physical function, neuromuscular strength, cardiopulmonary exercise testing, and biomarkers. This will be followed by practical session of the exercise prescriptions that we implement including both aerobic and resistance training methodologies.

Presenters will include:

  • Prof Robert Newton, Director, ECU Health and Wellness Institute
  • Prof Daniel Galvao, Director, ECU Health and Wellness Institute
  • Prof Lee Jones, Memorial Sloan Kettering Cancer Center
  • Dr Prue Cormie, Senior Research Fellow, ECU Health and Wellness Institute
  • Dr Carolyn McIntyre, Postdoctoral Fellow, ECU Health and Wellness Institute
  • Dr Nicolas Hart, Postdoctoral Fellow, ECU Health and Wellness Institute
  • Dr Eva Zopf, Postdoctoral Fellow, ECU Health and Wellness Institute

Catering: Light refreshments and snacks will be provided.

No charge for delegates.
A bus will be provided from the city centre to Joondalup and return.

Please contact Cailyn Rogers to attend:
Cailyn Rogers
T: 08 6304 3984


Workshop: Advances in Personalised Medicine 

Date:       20th April 2015
Time:       9.00am - 4.30pm (Registration 8.30am)
Venue:          McCusker Conference Centre, Institute for Immunology and Infectious Diseases, Murdoch University

Session 1: 9.00am – 1.00pm: Building on Successful Science and Translation

This session will focus on personalised approaches and innovation in the realm of human and cancer genomics and how translational approaches differ between these two domains.

  • Prof Elizabeth Phillips, Director, Centre for Clinical Pharmacology and Infectious Diseases: “Personalized approaches to severe immunologically mediated drug reactions”: Abacavir hypersensitivity and HLA-B*57:01 as a roadmap for science and translation’
  • Prof Simon Mallal, Director, Institute for Immunology and Infectious Diseases: ‘Personalised Immunology’
  • Prof Jennifer Martin, Chair of Clinical Pharmacology, University of Newcastle: ‘Personalised Pharmacology’
  • Dr Tom Stricker, Director,  Center for Advanced lab Diagnostics, Vanderbilt University: ‘Cancer panels: state of the art’
  • Prof David Thomas, Director, Kinghorn Cancer Centre, Garvan Institute: ‘Somatic and germline cancer genomics’
  • Professor Paul Waring, Director, Centre for Translational Pathology, University of Melbourne: ‘How laboratory medicine is adapting to support personalized medicine’
  • Assoc. Prof Rob Trengove, Director, Separation Science and Metabolomics Laboratory: ‘How metabolomics  is being leveraged to improve patient care; looking from the other end of the street’

1.00pm         Lunch and optional tour of Institute for Immunology and Infectious Diseases to demonstrate enabling technologies

Session 2: 2.00pm – 4.30pm: Precision Medicine

Precision medicine brings together the appropriate treatment based on an integrative approach to molecular and clinical diagnostics and best practice management of the individual’s condition. In the genomic era individual variations profoundly affect the response to treatment and disease progression. In this workshop, we will consider various dimensions required to deliver safe and effective therapeutics including molecular medicines, particularly to those with inherited and acquired disorders.

The afternoon session will be conducted as a round table workshop to cover the following themes: patient-centred registries, biobanks and ethics, bioinformatics and integrative –omics analysis, molecular therapies, animal models for personalized medicine, new therapeutic strategies.  Audience participation is strongly encouraged to discuss issues influencing successful implementation of new therapies. 

  • Prof Matt Bellgard, Director, of the Centre for Comparative Genomics (CCG), Foundation Chair in Bioinformatics
  • Prof Steve Wilton, Foundation Chair in Molecular Therapies (CCG) and Director of Western Australian Neuroscience Research Institute (WANRI)
  • Prof Sue Fletcher, Principal Research Fellow (CCG/WANRI)
  • Dr Rakesh Veedu, McCusker Research Fellow (CCG/WANRI) 

Panel Discussion with all speakers from morning & afternoon sessions: ‘How the science can most immediately improve care of the patient’ 

5.00pm       BBQ Sundowner with light refreshments and snacks

Catering: Participants may register for morning and/or afternoon session, lunch and/or the BBQ Sundowner.

No charge for delegates.
A bus will be provided from the city centre to Murdoch and return.  

Contact to attend:
Ruth Warren
T: 08 9360 1314

Alli Mackinnon
T: 08 9360 6088


Workshop: Consumer and Community Participation in Health Research:
A Training Workshop for Researchers
Date: 20th April 2015
Time: 8.45am - 4.00pm
Venue: The University of Notre Dame Australia, Building ND42 (Michael Keating Room), Cliff St, Fremantle
Science on the Swan Conference Delegates will be collected from the Perth Convention Centre at 8:00am and drop off at Notre Dame. When the workshop has closed, the shuttle bus will collect Delegates from Notre Dame and return to the Perth Convention Centre (arriving at approximately 5:00pm).

Catering: Morning coffee/tea and lunch will be provided.

Cost: Free of charge for registrants.

Please note:
A cancellation fee (equivalent to the actual cost of the workshop) may apply to registrants who fail to attend without notifying the Research Office in advance.
Aims of the workshop 
The aims of the workshop are to: 
• Raise awareness of the contribution consumers and the community can make to research when involved
  as active partners 
• Identify and address barriers to consumer and community participation 
• Develop ways to start involving consumers and the community as partners in research, and to develop good practice in
  consumer and community participation 
• Encourage and support researchers and students who have an interest in consumer and community
  participation in research 
By the end of the workshop, it is anticipated researchers will: 
• Be able to identify why and how consumers and the community can contribute to research 
• Have an awareness of researcher and consumer perspectives and experiences of working with consumers
  and the community 
• Have knowledge about organisations that are working towards increasing consumer and community
   participation in research activities and the support and/or help these organisations can provide 
• Start to consider how the theories and examples of good practice covered in the workshop can be
          utilised in research 
Overview of topics that will be covered 
• What is consumer and community involvement? 
• Why it’s important and what are the benefits? 
• Barriers to consumer and community involvement 
• Writing in plain language 
• Good practice examples and methods of consumer and community involvement 

Please RSVP by 13th April 2015

RSVP’s are essential as places are limited to 30 people. Please indicate any special requirements.
Please contact Hayley Coppinger to attend: 
Hayley Coppinger

T: 08 9433 0565

Workshop: Microbiome on the Swan: Foundations and Future Directions
Date: 20th April 2015
Time: 8.30am - 3.30pm (Registration 8.00am)
Venue: Nedlands Yacht Club, The Esplanade, Nedlands (
Registration fee: $20 – pay on arrival (cash only)
Synopsis and objectives

Microbiome analysis and metagenomics are rapidly becoming an integral part of many disciplines of research – from health & medicine to agriculture and soil science. The number of microbiome-related publications increased from 166 in 2004 to 4691 in 2014!

In WA, microbiome research has for the most part been fragmented and conducted in isolation by individual research groups, often with technical assistance from overseas partners. However, with the growing accessibility of NGS platforms and expertise in metagenomics analysis, the field is quickly moving from the domain of niche laboratories to mainstream science.

The aim of this symposium is to bring together research groups working within WA in the field of microbiome and microbial genomics to discuss achievements to date and future challenges, opportunities for collaboration, avenues for expansion and development. The invited speakers represent different disciplines and organisations; all will present data from their own studies and insights as to where this research might be heading in the future.

The possibility of establishing a centre for microbiome research in W.A., covering the spectrum of interests including human, animal, plant, soil and marine microbiomes, will be explored in the final segment of the day’s proceedings.
Please contact Jeffrey Keelan to attend: 
Jeffrey Keelan

T: 08 9340 1880


Post-Conference Workshops

Workshop: Faculty of Health Sciences, Curtin University

Date: 24th April 2015
Time: 8.30am - 5.00pm
Venue: Room 104.101, Curtin University

Presentations Include:

  • “Cancer stem cells : the enemy within”
  • Professor Gail P. Risbridger
  • ‘Blood based biomarkers of disease diagnosis, progression and response to treatment in melanoma’
  • Professor Mel Ziman
  • “Manipulating neural stem cells to model brain cancer”
  • Dr Raelene Endersby
  • "TWEAK/Fn14 signalling as a marker of cholangiocarcinoma"
  • Dr Nina Trinitz-Parker
  • "Targeting leukaemia stem cells: self-renewal and epigenetics”
  • Dr. Jenny Y. Wang
  • “Computational aspects of analysis of large scale data”
  • Professor Shekar Mande
  • Functional Characterization of CD133+ Cancer Stem Cells in Melanoma Progression and Angiogenesis"
  • Dr Gopal Kundu
  • Potential application of gamma-tocotrienol as a novel chemosensitizer and angiogenesis inhibitor in gastric cancer”
  • Associate Professor Gautam Sethi
  • DEAD-box RNA Helicase DP103 as a Biomarker for Therapeutic Response to Docetaxel”
  • Dr Alan Kumar


Please contact Arun Dharmarajan to attend: 
Professor Arun Dharmarajan
T: 08 9266 9867